Fact CheckerSign in

NCT06899191Completed

Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED

Diabetes Electronic Prompt for Improved Care Coordination and Treatment (DEPICCT) in the ED

Source: ClinicalTrials.gov · Last updated 30 Apr 2026

Brief summary (registry, in English)

The goal of this clinical trial is to improve the processes of Type 2 Diabetes (T2D) care coordination and treatment in the emergency department (ED) by utilizing clinical decision support mechanisms in the electronic health record (EHR). The main question is whether electronic prompts triggered by hyperglycemia and elevated A1c results in providers providing earlier treatments and faster time to subsequent primary care appointment and greater reduction in hemoglobin A1c (HA1c). ED clinicians will receive alerts called Our Practice Advisories (OPA's) through the EPIC EHR. The 1st OPA triggers when a random point-of-care (POC) glucose is ≥250 mg/dL, prompting a suggested additional HA1c order. A 2nd OPA triggers if the resulting HA1c is ≥10%, prompting consideration of further care coordination in the Observation Unit. Investigators will compare the outcomes post-intervention compared to pre-intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
300 (actual)
First submitted
21 Mar 2025
Start date
30 Mar 2025
Primary completion date
1 Apr 2026
Lead sponsor
Rutgers, The State University of New Jersey
NCT number
NCT06899191

What you commit to

  • Study type: Interventional
  • Participants enrolled: 300
  • From 30 Mar 2025 to the primary completion date, 1 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Diabetic foot ulcer or skin complications
  • Hyperglycemic hyperosmolar state with neurologic impairment

Other

  • Diabetic ketoacidosis (pH \< 7.20, HCO3 \< 15, AG \> 25)
  • Patients who leave against medical advice (AMA), elope from the ED, or are transferred to another facility

Who the study is looking for

  • Moderate hyperglycemia, (glucose ≥250 mg/dL)
  • Patients who arrive in the emergency department
  • Not pregnant or peri-partum
  • Not SARS-COV-2 PCR positive in past 7 days

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rutgers, Robert Wood Johnson Hospital
Coordinator of this site? Confirm its status
New BrunswickUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.